Skip to main content
logo
Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,891.00
-75.00 (-3.81%)
At close: Oct 22, 2026

Kangstem Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
177,856218,206113,229133,971109,830124,057
Market Cap Growth
34.69%92.71%-15.48%21.98%-11.47%-36.85%
Enterprise Value
159,631199,99595,018129,76185,183115,828
Last Close Price
1891.002320.001689.512003.152103.332375.78

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
58.6161.0814.6210.556.7410.00
PB Ratio
3.143.162.622.672.081.74
P/TBV Ratio
4.454.182.682.822.271.85

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
52.6055.9812.2710.215.239.34

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.160.140.200.270.250.20
Net Debt / Equity Ratio
-0.32-0.42-0.23-0.47-0.44-0.60
Net Debt / EBITDA Ratio
1.061.910.851.261.402.26
Net Debt / FCF Ratio
1.072.360.501.331.191.97
Asset Turnover
-0.050.110.160.180.13
Inventory Turnover
-3.264.7621.1618.5717.37
Quick Ratio
3.574.752.922.072.733.38
Current Ratio
3.965.253.692.553.223.80
Return on Equity (ROE)
--18.65%-15.18%-45.17%-32.55%-36.40%
Return on Assets (ROA)
--16.06%-13.52%-17.59%-13.99%-15.31%
Return on Capital Employed (ROCE)
-31.60%-24.10%-30.80%-36.40%-31.00%-26.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.92%-4.80%-6.77%-16.38%-18.43%-17.21%
FCF Yield
-9.56%-5.65%-17.29%-13.35%-17.82%-17.43%
Buyback Yield / Dilution
-63.45%-24.08%-37.93%-7.02%-36.23%-24.89%